All Articles
It’s important to understand the nuances of this test, along with your family history, so you can make an informed decision on when to begin testing and how frequently. Read More ›
Knowing if the patient’s chronic lymphocytic leukemia (CLL) has genetic abnormalities through genetic testing can help doctors select the best treatment. Read More ›
In July 2018, the FDA approved Tibsovo (ivo-sidenib; from Agios Pharmaceuticals), the first IDH1 inhibitor, for the treatment of adults with relapsed (returning) or refractory (not responding to treatment) acute myeloid leukemia (AML) and a susceptible IDH1 genetic mutation. Read More ›
Previously approved for thyroid cancer and kidney cancer, the FDA has recently approved Lenvima as the first treatment for patients with liver cancer. Read More ›
The use of Opdivo with Yervoy is the first immunotherapy combination therapy approved by the FDA for patients with kidney cancer. Read More ›
Breast cancer survivor Ginger Modiri cautions those in remission to avoid becoming complacent and to keep up with their follow-up screenings. Read More ›
Dr. Citrin explains the role of 5 experts who are essential for meeting the physical, emotional, and therapy needs of patients with breast cancer. Read More ›
